Zacks Investment Research on MSN2h
JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's DiseaseJohnson & Johnson JNJ announced that the FDA has granted a Fast Track designation (“FTD’) to its investigational drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback